Sotorasib

1 Drug classified under this active ingredient

Antineoplastic. Sotorasib 120 mg, 240 mg.
Film-coated tablets: 960 mg (eight 120 mg tabs or four 240 mg tablets) once daily, at the same time each day.
Tmt. of adlt. Pts. with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC), as determined by an approved test, who have received at least one prior systemic therapy.
C/I: Hypersens.